4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Dimenhydrinate.
Abiraterone
The serum concentration of Dimenhydrinate can be increased when it is combined with Abiraterone.
Acepromazine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Acepromazine.
Advertisement
Aceprometazine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Aceprometazine.
Alfaxalone
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Alfaxalone.
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Dimenhydrinate.
Advertisement
Alphaprodine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Dimenhydrinate.
Amisulpride
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Amisulpride.
Advertisement
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dimenhydrinate.
Amobarbital
The risk or severity of adverse effects can be increased when Amobarbital is combined with Dimenhydrinate.
Amoxapine
The risk or severity of adverse effects can be increased when Amoxapine is combined with Dimenhydrinate.
Amphetamine
Amphetamine may decrease the sedative activities of Dimenhydrinate.
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Dimenhydrinate.
Articaine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Asenapine is combined with Dimenhydrinate.
Azelastine
Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Baclofen
The risk or severity of adverse effects can be increased when Baclofen is combined with Dimenhydrinate.
Barbital
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Barbital.
Benoxinate
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Benzocaine.
Benzphetamine
Benzphetamine may decrease the sedative activities of Dimenhydrinate.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Benzyl alcohol.
Benzylpenicilloyl polylysine
Dimenhydrinate may decrease effectiveness of Benzylpenicilloyl Polylysine as a diagnostic agent.
BETAHISTINE
The therapeutic efficacy of Betahistine can be decreased when used in combination with Dimenhydrinate.
Brexpiprazole
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Dimenhydrinate.
Bromazepam
The risk or severity of adverse effects can be increased when Bromazepam is combined with Dimenhydrinate.
Bromperidol
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Brompheniramine is combined with Dimenhydrinate.
Brotizolam
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Brotizolam.
Bupivacaine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Bupivacaine.
Buprenorphine
Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Dimenhydrinate.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Dimenhydrinate.
Butalbital
The risk or severity of adverse effects can be increased when Butalbital is combined with Dimenhydrinate.
Butamben
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Butethal.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Dimenhydrinate.
Carbamazepine
The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dimenhydrinate.
Carbinoxamine
The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Dimenhydrinate.
Carisoprodol
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Dimenhydrinate.
Cetirizine
The risk or severity of adverse effects can be increased when Cetirizine is combined with Dimenhydrinate.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Chloral hydrate.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Dimenhydrinate.
Chlormethiazole
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Chloroprocaine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Chlorphenamine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Dimenhydrinate.
Chlorprothixene
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Chlorprothixene.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Dimenhydrinate.
Ciprofloxacin
The serum concentration of Dimenhydrinate can be increased when it is combined with Ciprofloxacin.
Citalopram
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Citalopram.
Clemastine
The risk or severity of adverse effects can be increased when Clemastine is combined with Dimenhydrinate.
Clidinium
The risk or severity of adverse effects can be increased when Clidinium is combined with Dimenhydrinate.
Clidinium bromide
The risk or severity of adverse effects can be increased when Clidinium is combined with Dimenhydrinate.
Clobazam
The risk or severity of adverse effects can be increased when Clobazam is combined with Dimenhydrinate.
Clomipramine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Clonazepam.
Clonidine
The risk or severity of adverse effects can be increased when Clonidine is combined with Dimenhydrinate.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Dimenhydrinate.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Dimenhydrinate.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Dimenhydrinate.
Cocaine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Dimenhydrinate.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Dimenhydrinate.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Dimenhydrinate.
Cyclizine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Dimenhydrinate.
Cyproheptadine
The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Dimenhydrinate.
Dantrolene
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Dantrolene.
Dapiprazole
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Dapiprazole.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Dimenhydrinate.
Desipramine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Desloratadine is combined with Dimenhydrinate.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Desvenlafaxine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Dimenhydrinate.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Dexmedetomidine.
Dextroamphetamine
Dextroamphetamine may decrease the sedative activities of Dimenhydrinate.
Dextromoramide
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Dimenhydrinate.
Dibucaine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Cinchocaine.
Diethylpropion
Diethylpropion may decrease the sedative activities of Dimenhydrinate.
Difenoxin
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Difenoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Dimenhydrinate.
Diphenhydramine
The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Dimenhydrinate.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Dimenhydrinate.
Dothiepin
The serum concentration of Dimenhydrinate can be increased when it is combined with Dosulepin.
Doxepin
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Doxepin.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Dimenhydrinate.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dimenhydrinate.
Duloxetine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Dyclonine.
Efavirenz
The risk or severity of adverse effects can be increased when Efavirenz is combined with Dimenhydrinate.
Enflurane
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Entacapone is combined with Dimenhydrinate.
Escitalopram
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Escitalopram.
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Dimenhydrinate.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Dimenhydrinate.
Ethanol
Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Ethosuximide is combined with Dimenhydrinate.
Ethotoin
The risk or severity of adverse effects can be increased when Ethotoin is combined with Dimenhydrinate.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Etomidate.
Ezogabine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Felbamate is combined with Dimenhydrinate.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Dimenhydrinate.
Fexofenadine
The risk or severity of adverse effects can be increased when Fexofenadine is combined with Dimenhydrinate.
Fleroxacin
The serum concentration of Dimenhydrinate can be increased when it is combined with Fleroxacin.
Flibanserin
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Flibanserin.
Flunarizine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Flunarizine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Flunitrazepam.
Fluoxetine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Flupentixol is combined with Dimenhydrinate.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Dimenhydrinate.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Dimenhydrinate.
Fluspirilene
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Dimenhydrinate.
Fluvoxamine
The serum concentration of Dimenhydrinate can be increased when it is combined with Fluvoxamine.
Fosphenytoin
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Fospropofol.
Gabapentin
The risk or severity of adverse effects can be increased when Gabapentin is combined with Dimenhydrinate.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Gabapentin Enacarbil.
Glutethimide
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Glutethimide.
Guanfacine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Halazepam.
Haloperidol
The risk or severity of adverse effects can be increased when Haloperidol is combined with Dimenhydrinate.
Halothane
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Heroin.
Hexobarbital
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Hexobarbital.
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Dimenhydrinate.
Hyaluronidase, Ovine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Dimenhydrinate.
Hydrocodone
Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Dimenhydrinate.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dimenhydrinate.
Iloperidone
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Iloperidone.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Dimenhydrinate.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Dimenhydrinate.
Ketamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Dimenhydrinate.
Ketazolam
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Ketazolam.
Lamotrigine
The risk or severity of adverse effects can be increased when Lamotrigine is combined with Dimenhydrinate.
Levetiracetam
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Levetiracetam.
Levobupivacaine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Levocetirizine.
Levodopa
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Levodopa.
Levomethadyl
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Dimenhydrinate.
Lidocaine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Lidocaine.
Lisdexamfetamine
Lisdexamfetamine may decrease the sedative activities of Dimenhydrinate.
Lisdexamfetamine Dimesylate
Lisdexamfetamine may decrease the sedative activities of Dimenhydrinate.
Lithium
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Lithium.
Lofexidine
The therapeutic efficacy of Dimenhydrinate can be increased when used in combination with Lofexidine.
Loratadine
The risk or severity of adverse effects can be increased when Loratadine is combined with Dimenhydrinate.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Dimenhydrinate.
Lormetazepam
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Lormetazepam.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Dimenhydrinate.
Lurasidone
The risk or severity of adverse effects can be increased when Lurasidone is combined with Dimenhydrinate.
Magnesium Sulfate
The therapeutic efficacy of Dimenhydrinate can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Dimenhydrinate can be increased when used in combination with Magnesium sulfate.
Maprotiline
The risk or severity of adverse effects can be increased when Maprotiline is combined with Dimenhydrinate.
Meclizine
The risk or severity of adverse effects can be increased when Meclizine is combined with Dimenhydrinate.
Melatonin
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Dimenhydrinate.
Mephentermine
Mephentermine may decrease the sedative activities of Dimenhydrinate.
Mephobarbital
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Methylphenobarbital.
Mepivacaine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Dimenhydrinate.
Mesoridazine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Mesoridazine.
Metaxalone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Dimenhydrinate.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Dimenhydrinate.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Methadyl Acetate.
Methamphetamine
Methamphetamine may decrease the sedative activities of Dimenhydrinate.
Methapyrilene
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Methaqualone.
Methocarbamol
The risk or severity of adverse effects can be increased when Methocarbamol is combined with Dimenhydrinate.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Dimenhydrinate.
Methotrimeprazine
Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Methsuximide.
Metylperon
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Melperone.
Metyrosine
Dimenhydrinate may increase the sedative activities of Metyrosine.
Mexiletine
The serum concentration of Dimenhydrinate can be increased when it is combined with Mexiletine.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Dimenhydrinate.
Midostaurin
The serum concentration of Dimenhydrinate can be increased when it is combined with Midostaurin.
Milnacipran
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Dimenhydrinate.
Mirtazapine
Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Molindone
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Molindone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Dimenhydrinate.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Dimenhydrinate.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Dimenhydrinate.
Nefazodone
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Nefazodone.
Nitrazepam
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Dimenhydrinate.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Dimenhydrinate.
Nordazepam
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Nordazepam.
Norflurane
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Dimenhydrinate.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Dimenhydrinate.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Dimenhydrinate.
Ondansetron
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Opium.
Orphenadrine
Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Dimenhydrinate.
Oxprenolol
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Dimenhydrinate.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Dimenhydrinate.
p-Hydroxyamphetamine
Hydroxyamphetamine may decrease the sedative activities of Dimenhydrinate.
Paliperidone
The risk or severity of adverse effects can be increased when Paliperidone is combined with Dimenhydrinate.
Paraldehyde
Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Dimenhydrinate.
Paroxetine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Paroxetine.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Dimenhydrinate.
Pentobarbital
The risk or severity of adverse effects can be increased when Pentobarbital is combined with Dimenhydrinate.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Dimenhydrinate.
Perazine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Perazine.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Dimenhydrinate.
Phenobarbital
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Dimenhydrinate.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Phenoxyethanol.
Phentermine
Phentermine may decrease the sedative activities of Dimenhydrinate.
PHENTERMINE RESIN
Phentermine may decrease the sedative activities of Dimenhydrinate.
Phenytoin
The risk or severity of adverse effects can be increased when Phenytoin is combined with Dimenhydrinate.
Pimozide
The risk or severity of adverse effects can be increased when Pimozide is combined with Dimenhydrinate.
Pipamperone
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Pipotiazine.
Pirinitramide
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Pizotifen.
Pomalidomide
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Pomalidomide.
Pramipexole
Dimenhydrinate may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Dimenhydrinate can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Prilocaine.
Primidone
The risk or severity of adverse effects can be increased when Primidone is combined with Dimenhydrinate.
Procaine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Procaine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Dimenhydrinate.
Promazine
The risk or severity of adverse effects can be increased when Promazine is combined with Dimenhydrinate.
Promethazine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Promethazine.
Proparacaine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Proparacaine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Dimenhydrinate.
Propoxyphene
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Dextropropoxyphene.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Dimenhydrinate.
Pseudoephedrine
Pseudoephedrine may decrease the sedative activities of Dimenhydrinate.
Quazepam
The risk or severity of adverse effects can be increased when Quazepam is combined with Dimenhydrinate.
Quetiapine
The risk or severity of adverse effects can be increased when Quetiapine is combined with Dimenhydrinate.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Quetiapine is combined with Dimenhydrinate.
Ramelteon
The risk or severity of adverse effects can be increased when Ramelteon is combined with Dimenhydrinate.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Dimenhydrinate.
Remoxipride
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Dimenhydrinate.
Risperidone
The risk or severity of adverse effects can be increased when Risperidone is combined with Dimenhydrinate.
Ropinirole
Dimenhydrinate may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Ropivacaine.
Rotigotine
Dimenhydrinate may increase the sedative activities of Rotigotine.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Dimenhydrinate.
Scopolamine
The risk or severity of adverse effects can be increased when Scopolamine is combined with Dimenhydrinate.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Scopolamine is combined with Dimenhydrinate.
Secobarbital
The risk or severity of adverse effects can be increased when Secobarbital is combined with Dimenhydrinate.
Sertindole
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Sertindole.
Sertraline
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Dimenhydrinate.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Dimenhydrinate.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Dimenhydrinate.
Sulpiride
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Sulpiride.
Suvorexant
Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Dimenhydrinate.
Tasimelteon
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Tasimelteon.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Dimenhydrinate.
Tetrabenazine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Tetrabenazine.
Tetracaine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Dimenhydrinate.
Thalidomide
Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thiamylal
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Thiamylal.
Thiopental
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Thiopental.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Thiopental.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Dimenhydrinate.
Thiothixene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Dimenhydrinate.
Tiagabine
The risk or severity of adverse effects can be increased when Tiagabine is combined with Dimenhydrinate.
Tiapride
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Tiapride.
Tizanidine
The risk or severity of adverse effects can be increased when Tizanidine is combined with Dimenhydrinate.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Dimenhydrinate.
Topiramate
The risk or severity of adverse effects can be increased when Topiramate is combined with Dimenhydrinate.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Dimenhydrinate.
Tranylcypromine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Trazodone.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Dimenhydrinate.
Triazulenone
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Dimenhydrinate.
Triflupromazine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Triflupromazine.
Trimipramine
The risk or severity of adverse effects can be increased when Trimipramine is combined with Dimenhydrinate.
Triprolidine
The risk or severity of adverse effects can be increased when Triprolidine is combined with Dimenhydrinate.
Urethane
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Ethyl carbamate.
Valproate
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Valproic Acid.
Valproic Acid
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Valproic Acid.
Venlafaxine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Venlafaxine.
Vigabatrin
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Vigabatrin.
Vortioxetine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Vortioxetine.
Xylazine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Xylazine.
Zaleplon
The risk or severity of adverse effects can be increased when Zaleplon is combined with Dimenhydrinate.
Ziconotide
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Ziconotide.
Ziprasidone
The risk or severity of adverse effects can be increased when Ziprasidone is combined with Dimenhydrinate.
Zolpidem
Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Zonisamide is combined with Dimenhydrinate.
Zopiclone
The risk or severity of adverse effects can be increased when Zopiclone is combined with Dimenhydrinate.
Zotepine
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Dimenhydrinate.
